The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

M. Haas, A. Loupy, C. Lefaucheur, C. Roufosse, D. Glotz, D. Seron, B. J. Nankivell, P. F. Halloran, R. B. Colvin, Enver Akalin, N. Alachkar, S. Bagnasco, Y. Bouatou, J. U. Becker, L. D. Cornell, J. P.Duong van Huyen, I. W. Gibson, Edward S. Kraus, R. B. Mannon, M. NaesensV. Nickeleit, P. Nickerson, D. L. Segev, H. K. Singh, M. Stegall, P. Randhawa, L. Racusen, K. Solez, M. Mengel

Research output: Contribution to journalArticlepeer-review

405 Scopus citations

Fingerprint

Dive into the research topics of 'The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences